Concepedia

Author

Susan R. Rheingold

Children's Hospital of PhiladelphiaORCID

Also Known As

S. R. Rheingold, S. Rheingold, S.R. Rheingold, Susan R Rheingold, Susan R. Rheingold, Susan Rheingold

218

Publications

15.9K

Citations

43

H-Index

75

Concepts

All Affiliations

Children's Hospital of PhiladelphiaUniversity of PennsylvaniaChildren's Hospital of Los AngelesUniversity of Colorado DenverSt. Jude Children's Research Hospital
SR

About

Susan R. Rheingold is an author at Children's Hospital of Philadelphia specializing in medicine, hematology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

26

4.9K

2

Health Sciences

11

11

651

3

Cell Biology

5

5

3.5K

4

Public Health

4

4

130

5

Allergy

1

1

148

Susan R. Rheingold

×

85

Publications

15.1K

Citations

38

H-Index

YearCitations

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

Shannon L. Maude, Noelle V. Frey, Pamela A. Shaw,

New England Journal of Medicine

2014

5.3K

Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

Stephan A. Grupp, Michael Kalos, David M. Barrett,

New England Journal of Medicine

2013

3.4K

Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia

David T. Teachey, Simon F. Lacey, Pamela A. Shaw,

Cancer Discovery

2016

1.1K

Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy

David T. Teachey, Susan R. Rheingold, Shannon L. Maude,

Blood

2013

609

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Arend von Stackelberg, Franco Locatelli, Gerhard Zugmaier,

Journal of Clinical Oncology

2016

597

Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia

Sima Jeha, Paul S. Gaynon, Bassem I. Razzouk,

Journal of Clinical Oncology

2006

304

Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

Deepa Bhojwani, Richard Sposto, Nirali N. Shah,

Leukemia

2018

202

CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy

Vinodh Pillai, Kavitha Muralidharan, Wenzhao Meng,

Blood Advances

2019

196

Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia

Regina M. Myers, Yimei Li, Allison Barz Leahy,

Journal of Clinical Oncology

2021

177

Sustained remissions with CD19-specific chimeric antigen receptor (CAR)-modified T cells in children with relapsed/refractory ALL.

Shannon L. Maude, David T. Teachey, Susan R. Rheingold,

Journal of Clinical Oncology

2016

148

Page 1